Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Plasmodium spp. is a genus of unicellular protozoan parasites responsible for causing malaria. These parasites have a complex life cycle involving both mosquito and vertebrate hosts. They undergo asexual reproduction in the vertebrate host, leading to the destruction of red blood cells and the symptoms of malaria. The life cycle stages and molecular features of Plasmodium, such as the circumsporozoite protein (CSP), are targets for drug and vaccine development. Different species of Plasmodium, including P. falciparum, P. vivax, P. ovale, P. malariae, and P. knowlesi, infect humans and cause varying degrees of disease severity.
Varies depending on the drug; examples include inhibiting parasite enzymes, disrupting DNA replication, or interfering with electron transport.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plasmodium spp..